cobas egfr mutation test | cobas® EGFR Mutation Test v2

Keyword	CPC	PCC	Volume	Score	Length of keyword
cobas egfr mutation test	0.5	0.3	9582	26	24
cobas	0.64	0.2	5057	14	5
egfr	0.88	0.7	9592	25	4
mutation	1.85	1	9522	96	8
test	0.15	0.8	298	94	4

Keyword	CPC	PCC	Volume	Score
cobas egfr mutation test	1.49	0.7	602	95

Search Results related to cobas egfr mutation test on Search Engine

cobas® EGFR Mutation Test v2 | Roche Molecular Diagnostics
roche.com

https://diagnostics.roche.com/us/en/products/params/cobas-egfr-mutation-test-v2.html

WEBClear results. Confident decisions. The cobas® EGFR Mutation Test v2 is a real-time PCR test that identifies 42 mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor (EGFR) gene, including the T790M resistance mutation. It is designed to enable testing of both tissue and plasma specimens with a single kit, and allows ...

DA: 14 PA: 23 MOZ Rank: 37

cobas® EGFR Mutation Test v2 - Roche Diagnostics USA
roche.com

https://diagnostics.roche.com/gb/en/products/params/cobas-egfr-mutation-test-v2.html

WEBClear results. Confident decisions. The cobas® EGFR Mutation Test v2 is a real-time PCR test that identifies 42 mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor ( EGFR) gene, including the T790M resistant mutation. It is designed to enable testing of both tissue and plasma specimens with a single kit, and allows ...

DA: 85 PA: 41 MOZ Rank: 34

cobas EGFR Mutation Test v2 | FDA
fda.gov

https://www.fda.gov/drugs/resources-information-approved-drugs/cobas-egfr-mutation-test-v2

WEBThe cobas EGFR Mutation Test v2 for use with plasma test is intended to be used to initially screen patients with metastatic NSCLC for EGFR mutations. Those patients in whom no exon...

DA: 73 PA: 36 MOZ Rank: 74

cobas EGFR Mutation Test v2 - Food and Drug Administration
fda.gov

https://www.accessdata.fda.gov/cdrh_docs/pdf12/P120019S007c.pdf

WEBEGFR Mutation Test v2 (cobas EGFR Test) is a real-time PCR assay designed to detect G719X substitution mutations in exon 18, deletion mutations in exon 19, T790M and S768I substitution

DA: 96 PA: 41 MOZ Rank: 52

Cobas® EGFR (Epidermal Growth Factor Receptor) Mutation Test ... - Labcorp
labcorp.com

https://www.labcorp.com/tests/489067/cobas-i-egfr-i-epidermal-growth-factor-receptor-mutation-test-v2-ivd

WEBThe FDA approved cobas® EGFR Mutation Test v2 is a real-time PCR test for the qualitative detection of defined mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC) patients.

DA: 30 PA: 64 MOZ Rank: 22

cobas® EGFR Mutation Test v2 - Roche Diagnostics USA
roche.com

https://diagnostics.roche.com/se/sv/products/params/cobas-egfr-mutation-test-v2.html

WEBThe cobas® EGFR Mutation Test v2 is a real-time polymerase chain reaction (PCR) test that identifies 42 mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor (EGFR) gene, including the T790M resistance mutation. 1.

DA: 49 PA: 26 MOZ Rank: 22

cobas EGFR Mutation Test v2
roche.com

https://elabdoc-prod.roche.com/eLD/api/downloads/3a5ff04e-7e15-e711-00ab-00215a9b3428?countryIsoCode=kr

WEBEGFR Mutation Test v2 (cobas®EGFR Test) is a research use only real-time PCR test for the qualitative detection and semi-quantitative measurement of defined mutations of the epidermal growth factor receptor (EGFR) gene.

DA: 13 PA: 72 MOZ Rank: 74

EGFR Mutation Analysis - Cobas® V2 Assay - Labcorp
labcorp.com

https://oncology.labcorp.com/tests/489067/egfr-mutation-analysis-cobas-v2-assay

WEBThe FDA approved cobas® EGFR Mutation Test v2 is a real-time PCR test for the qualitative detection of defined mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor ( EGFR) gene in non-small cell lung cancer (NSCLC) patients.

DA: 40 PA: 43 MOZ Rank: 57

cobas EGFR Mutation Test v2
roche.com

https://elabdoc-prod.roche.com/LifeScience/Document/17f87b0f-9243-eb11-0291-005056a71a5d

WEBThe cobas® EGFR Mutation Test v2 (cobas EGFR Test) is a real-time PCR assay designed to detect G719X substitution mutations in exon 18, deletion mutations in exon 19, T790M and S768I substitution mutations in exon 20, insertion mutations in exon 20, and L858R and L861Q substitution mutations in exon 21.

DA: 100 PA: 28 MOZ Rank: 52

FDA approves first blood test to detect gene mutation associated …
fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-blood-test-detect-gene-mutation-associated-non-small-cell-lung-cancer

WEBWith the cobas EGFR Mutation Test v2, the presence of specific NSCLC mutations [exon 19 deletion or exon 21 (L858R) substitution mutations] detected in patients’ blood samples aids in...

DA: 75 PA: 28 MOZ Rank: 67